
Tenax Therapeutics, Inc.: shareholders and insiders
Price
$1.25
November 20, 2026Market cap $57M
What Ploutos Investor adds for Tenax Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from FY2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 23% since Nov 5, 2026, when the 10-Q these figures come from was filed ($1.63 then, $1.25 on Nov 20, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Oct 21, 2026, from their own Form 4 filings.
Bought on the market
$6.5M
5 people
Sold on the market
–
nobody
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $6.4M by 5 people·no sales
- 2025: bought $96.4K by 1 person, no sales
- 2026: bought $6.4M by 5 people, no sales
- Oct 21, 2026ADAR1 Capital Management, LLCKind
- Oct 20, 2026ADAR1 Capital Management, LLCKind
- Oct 19, 2026ADAR1 Capital Management, LLCKind
- Sep 16, 2026Declan DooganDirectorKind
- Sep 15, 2026Christopher Thomas GiordanoCEOKind
- Sep 11, 2026Christopher Thomas GiordanoCEOKind
- Sep 11, 2026Thomas R Staab IiChief Financial OfficerKind
- Sep 3, 2026ADAR1 Capital Management, LLCKind
- Sep 2, 2026ADAR1 Capital Management, LLCKind
- Sep 1, 2026ADAR1 Capital Management, LLCKind
- Aug 31, 2026ADAR1 Capital Management, LLCKind
- Aug 24, 2026ADAR1 Capital Management, LLCKind
- Aug 21, 2026ADAR1 Capital Management, LLCKind
- Aug 20, 2026ADAR1 Capital Management, LLCKind
- Jul 13, 2026Christopher Thomas GiordanoCEOKind
- Jul 13, 2026Christopher Thomas GiordanoCEOKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | ADAR1 Capital Management, LLC | 332.0K | $1.66 | $550.7K | Form 4 | |
| Oct 20, 2026 | ADAR1 Capital Management, LLC | 254.3K | $1.60 | $405.7K | Form 4 | |
| Oct 19, 2026 | ADAR1 Capital Management, LLC | 336.5K | $1.51 | $507.0K | Form 4 | |
| Sep 16, 2026 | Declan DooganDirector | 53.0K | $1.92 | $101.8K | Form 4 | |
| Sep 15, 2026 | Christopher Thomas GiordanoCEO | 4,850 | $1.82 | $8.8K | Form 4 | |
| Sep 11, 2026 | Christopher Thomas GiordanoCEO | 6,000 | $1.88 | $11.3K | Form 4 | |
| Sep 11, 2026 | Thomas R Staab IiChief Financial Officer | 5,675 | $1.94 | $11.0K | Form 4 | |
| Sep 3, 2026 | ADAR1 Capital Management, LLC | 900.0K | $1.78 | $1.6M | Form 4 | |
| Sep 2, 2026 | ADAR1 Capital Management, LLC | 187.7K | $1.80 | $337.6K | Form 4 | |
| Sep 1, 2026 | ADAR1 Capital Management, LLC | 179.1K | $1.80 | $321.6K | Form 4 | |
| Aug 31, 2026 | ADAR1 Capital Management, LLC | 403.6K | $1.79 | $722.6K | Form 4 | |
| Aug 24, 2026 | ADAR1 Capital Management, LLC | 107.4K | $1.75 | $188.4K | Form 4 | |
| Aug 21, 2026 | ADAR1 Capital Management, LLC | 716.4K | $1.77 | $1.3M | Form 4 | |
| Aug 20, 2026 | ADAR1 Capital Management, LLC | 202.1K | $1.78 | $359.5K | Form 4 | |
| Jul 13, 2026 | Christopher Thomas GiordanoCEO | 219 | $3.55 | $777 | Form 4 | |
| Jul 13, 2026 | Christopher Thomas GiordanoCEO | 8,500 | $5.94 | $50.5K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 14, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by TENX's officers and directors from 2010 up to November 21, 2025, 16 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 11 more, back to 2010
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- ADAR1 Capital Management, LLCwith 1 more personShare of class14.0%
- Biotechnology Value Fund L Pwith 9 more personsShare of class9.99%
- Janus Henderson GroupShare of class9.99%
- RTW Investments, LPwith 1 more personShare of class9.90%
- Vestal Point Capital, LPwith 1 more personShare of class9.90%
- Vivo Opportunity Fund Holdings, L.P.with 1 more personShare of class9.00%
- BlackRock, Inc.Share of class7.50%
- Sphera Funds Management Ltd.with 2 more personsShare of class7.09%
- Dellora Investments Master Fund LPwith 2 more personsShare of class6.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLCwith 1 more person | 14.0% | 5.26M | Sep 8, 2026 | 13G | |
| Biotechnology Value Fund L Pwith 9 more persons | 9.99% | 3.11M | Aug 14, 20263 filings since Feb 17, 2026 | 13G/A | |
| Janus Henderson Group | 9.99% | 623.7K | Dec 8, 20254 filings since Feb 14, 2025 | 13G | |
| RTW Investments, LPwith 1 more person | 9.90% | 2.87M | Aug 14, 20264 filings since May 15, 2025 | 13G/A | |
| Vestal Point Capital, LPwith 1 more person | 9.90% | 2.47M | Nov 14, 2025 | 13G | |
| Vivo Opportunity Fund Holdings, L.P.with 1 more person | 9.00% | 3.46M | Aug 14, 2026 | 13G/A | |
| BlackRock, Inc. | 7.50% | 2.80M | Oct 27, 20262 filings since Jul 30, 2026 | 13G/A | |
| Sphera Funds Management Ltd.with 2 more persons | 7.09% | 2.66M | Oct 13, 20262 filings since Aug 27, 2026 | 13G/A | |
| Dellora Investments Master Fund LPwith 2 more persons | 6.40% | 2.40M | Oct 9, 20266 filings since Dec 5, 2024 | 13G/A |
Fell to 5% or less (16)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Adage Capital Management, L.P.2.26%Nov 12, 202613G/A
- Millennium Management LLC3.60%Oct 15, 202613G/A
- ING Groep N.V.0.00%Sep 11, 202613G/A
- FMR1.40%Sep 8, 202613G/A
- Venrock Healthcare Capital Partners III, L.P.4.70%Aug 14, 202613G/A
- Ikarian Capital, LLC2.90%Aug 14, 202613G/A
- Perceptive Advisors LLC4.50%Aug 14, 202613G/A
- Christopher Thomas Giordano13D4.32%Jul 31, 202613D/A
- T. Rowe Price Associates, Inc.2.20%Jun 5, 202613G/A
- Point72 Asset Management, L.P.3.10%May 15, 202613G/A
- Lind Global Fund II LP0.78%May 15, 202613G/A
- Logos Global Management LP3.00%May 15, 202613G/A
- Stonepine Capital Management, LLC3.70%May 15, 202613G/A
- Invus Public Equities, L.P.2.50%May 4, 202613G/A
- Morgan Stanley3.50%Apr 8, 202613G/A
- S.H.N. Financial Investments Ltd.4.99%Mar 18, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter+56%
- Renaissance TechnologiesIn the quarter
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.01% | |
| Citadel Advisors (Griffin) | – | – | 0.01% | |
| Millennium Mgmt (Englander) | 1.36M | +56% | $2.6M | 0.00% |
| Renaissance Technologies | – | – | 0.00% | |
| AQR Capital | 1.25M | $2.4M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 15.9% of its shares outstanding were held short, +0.7% since the report before.
- Shares held short
- 7.23M
- 15.9%
- Since the report before7.18M on Sep 30, 2026
- +0.7%
- 3.2
- 2.25M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 37%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 18.1K
- Nov 15, 2023: Shares held short 2.97M
- Nov 30, 2023: Shares held short 651.1K
- Dec 15, 2023: Shares held short 155.6K
- Dec 29, 2023: Shares held short 121.6K
- Jan 12, 2024: Shares held short 14.0K
- Jan 31, 2024: Shares held short 35.4K
- Feb 15, 2024: Shares held short 46.4K
- Feb 29, 2024: Shares held short 72.5K
- Mar 15, 2024: Shares held short 36.7K
- Mar 28, 2024: Shares held short 49.0K
- Apr 15, 2024: Shares held short 35.2K
- Apr 30, 2024: Shares held short 22.4K
- May 15, 2024: Shares held short 9,795
- May 31, 2024: Shares held short 6,392
- Jun 14, 2024: Shares held short 9,892
- Jun 28, 2024: Shares held short 11.8K
- Jul 15, 2024: Shares held short 23.9K
- Jul 31, 2024: Shares held short 10.4K
- Aug 15, 2024: Shares held short 115.9K
- Aug 30, 2024: Shares held short 90.9K
- Sep 13, 2024: Shares held short 50.3K
- Sep 30, 2024: Shares held short 29.1K
- Oct 15, 2024: Shares held short 21.0K
- Oct 31, 2024: Shares held short 105.8K
- Nov 15, 2024: Shares held short 120.9K
- Nov 29, 2024: Shares held short 130.6K
- Dec 13, 2024: Shares held short 204.5K
- Dec 31, 2024: Shares held short 218.2K
- Jan 15, 2025: Shares held short 222.9K
- Jan 31, 2025: Shares held short 217.2K
- Feb 14, 2025: Shares held short 419.5K
- Feb 28, 2025: Shares held short 381.7K
- Mar 14, 2025: Shares held short 373.5K
- Mar 31, 2025: Shares held short 364.3K
- Apr 15, 2025: Shares held short 336.1K
- Apr 30, 2025: Shares held short 308.3K
- May 15, 2025: Shares held short 310.3K
- May 30, 2025: Shares held short 310.5K
- Jun 13, 2025: Shares held short 311.4K
- Jun 30, 2025: Shares held short 337.0K
- Jul 15, 2025: Shares held short 336.4K
- Jul 31, 2025: Shares held short 334.6K
- Aug 15, 2025: Shares held short 326.9K
- Aug 29, 2025: Shares held short 297.7K
- Sep 15, 2025: Shares held short 275.4K
- Sep 30, 2025: Shares held short 553.7K
- Oct 15, 2025: Shares held short 754.3K
- Oct 31, 2025: Shares held short 762.3K
- Nov 14, 2025: Shares held short 758.2K
- Nov 28, 2025: Shares held short 600.5K
- Dec 15, 2025: Shares held short 531.1K
- Dec 31, 2025: Shares held short 93.1K
- Jan 15, 2026: Shares held short 196.4K
- Jan 30, 2026: Shares held short 119.7K
- Feb 13, 2026: Shares held short 124.2K
- Feb 27, 2026: Shares held short 120.4K
- Mar 13, 2026: Shares held short 152.9K
- Mar 31, 2026: Shares held short 172.7K
- Apr 15, 2026: Shares held short 194.5K
- Apr 30, 2026: Shares held short 730.7K
- May 15, 2026: Shares held short 775.9K
- May 29, 2026: Shares held short 792.0K
- Jun 15, 2026: Shares held short 767.5K
- Jun 30, 2026: Shares held short 1.79M
- Jul 15, 2026: Shares held short 2.05M
- Jul 31, 2026: Shares held short 2.56M
- Aug 14, 2026: Shares held short 5.47M
- Aug 31, 2026: Shares held short 9.28M
- Sep 15, 2026: Shares held short 5.50M
- Sep 30, 2026: Shares held short 7.18M
- Oct 15, 2026: Shares held short 7.23M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading51.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 51.6% of the shares in the reported trades were short sales, against 50.9% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 51.6%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 50.9%
- Change
- +0.7 pts
- Short sales a dayon average, of 613.0K shares
- 316.5K
- More than atof 3,666 US-listed companies, same days
- 54%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 53.6%
- Oct 15, 2026: Short sales 38.3%
- Oct 16, 2026: Short sales 51.4%
- Oct 19, 2026: Short sales 51.7%
- Oct 20, 2026: Short sales 60.5%
- Oct 21, 2026: Short sales 55.4%
- Oct 22, 2026: Short sales 43.6%
- Oct 23, 2026: Short sales 66.7%
- Oct 26, 2026: Short sales 67.1%
- Oct 27, 2026: Short sales 45.8%
- Oct 28, 2026: Short sales 52.7%
- Oct 29, 2026: Short sales 40.5%
- Oct 30, 2026: Short sales 51.5%
- Nov 2, 2026: Short sales 64.1%
- Nov 3, 2026: Short sales 58.7%
- Nov 4, 2026: Short sales 54.3%
- Nov 5, 2026: Short sales 54.4%
- Nov 6, 2026: Short sales 51%
- Nov 9, 2026: Short sales 31.2%
- Nov 10, 2026: Short sales 77.7%
- Nov 11, 2026: Short sales 33.3%
- Nov 12, 2026: Short sales 65%
- Nov 13, 2026: Short sales 56.6%
- Nov 16, 2026: Short sales 61%
- Nov 17, 2026: Short sales 47.1%
- Nov 18, 2026: Short sales 65.8%
- Nov 19, 2026: Short sales 42.3%
- Nov 20, 2026: Short sales 32.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- ADAR1 Capital Management, LLCTenPercentOwnerDirectly922.8K
- Daniel SchneebergerTenPercentOwnerDirectly–
- Declan DooganDirectorDirectly55.3K
- Christopher Thomas GiordanoCEODirectly22.2K
- Thomas R Staab IiChief Financial OfficerDirectly15.7K
- Stuart RichChief Medical OfficerDirectly5,266
- June Sherie AlmenoffDirectorDirectly1,993
- Thomas McgauleyInterim CFODirectly2,000
- Michael H. DavidsonDirectorDirectly2,881
- Gerald T ProehlDirectorDirectly1,667
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| ADAR1 Capital Management, LLCTenPercentOwner | 922.8K | 6.52M | Oct 21, 2026 | Form 4 |
| Daniel SchneebergerTenPercentOwner | – | 5.62M | Sep 2, 2026 | Form 4 |
| Declan DooganDirector | 55.3K | – | Sep 16, 2026 | Form 4 |
| Christopher Thomas GiordanoCEO | 22.2K | – | Sep 15, 2026 | Form 4 |
| Thomas R Staab IiChief Financial Officer | 15.7K | – | Sep 11, 2026 | Form 4 |
| Stuart RichChief Medical Officer | 5,266 | 5,000 | Dec 9, 2025 | Form 4 |
| June Sherie AlmenoffDirector | 1,993 | 1,993 | Nov 18, 2025 | Form 4 |
| Thomas McgauleyInterim CFO | 2,000 | 1,000 | Nov 17, 2025 | Form 4 |
| Michael H. DavidsonDirector | 2,881 | – | Aug 8, 2024 | Form 4 |
| Gerald T ProehlDirector | 1,667 | – | Aug 8, 2024 | Form 4 |
A lower bound: it counts only the 10 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.08%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.02%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
- DFAUDimensional US Core Equity Market ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- DFUSDimensional U.S. Equity Market ETFWeight in the fund0.00%
10 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 34
- Q4 2025: Managers 49
- Q1 2026: Managers 81
- Q2 2026: Managers 111
Institutional investors by quarter
The fund managers holding TENX, quarter by quarter, from Q3 2014 to Q2 2025, 20 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 111 managers held 30.34M shares, worth $441M. During the quarter 44 opened a position, 15 closed one, 37 added and 14 trimmed.
The largest holders, Q2 2026
- FMRIn the quarter×12.2
- Vivo CapitalIn the quarter×12.0
- BlackRockIn the quarter×102
- Perceptive AdvisorsIn the quarter+17%
- Vanguard Capital ManagementIn the quarter+335%
- Millennium Mgmt (Englander)In the quarter+64%
- Ikarian CapitalIn the quarter-23%
- Candriam S.C.A.In the quarter
- Citadel Advisors (Griffin)In the quarter+378%
- Rtw InvestmentsIn the quarter+88%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| FMR | 3.94M | ×12.2 | $57M |
| Vivo Capital | 2.50M | ×12.0 | $36M |
| BlackRock | 1.73M | ×102 | $25M |
| Perceptive Advisors | 1.70M | +17% | $25M |
| Vanguard Capital Management | 1.15M | +335% | $17M |
| Millennium Mgmt (Englander) | 876.2K | +64% | $13M |
| Ikarian Capital | 787.6K | -23% | $11M |
| Candriam S.C.A. | 749.6K | $11M | |
| Citadel Advisors (Griffin) | 728.6K | +378% | $11M |
| Rtw Investments | 696.6K | +88% | $10M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Tenax Therapeutics's filings show?
Who buys and sells is one part of Tenax Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have TENX's insiders bought or sold?
From Jul 14, 2026 to Oct 21, 2026 Tenax Therapeutics's insiders bought $6.4M and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold TENX?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $2.6M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.